adenosine triphosphate
Trials 12
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT03972683 | Apr 2019 → Jul 2021 | — | Colorado State University | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 0 | NCT03738943 | Feb 2019 → Jun 2021 | — | Colorado State University | Completed | No outcome recorded |
| Phase 14 trials | ||||||
| Phase 1 | NCT07085975 | Aug 2025 → Aug 2026 overdue | asthma | McMaster University | Recruiting | No outcome recorded |
| Phase 1 | NCT01919918 | Sep 2013 → Jan 2018 | heart failure | University of Utah | Completed | No outcome recorded |
| Phase 1 | NCT02833207 | Apr 2012 → Nov 2021 | obesity disorder | University of Wisconsin, Madison | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT00014248 | Oct 2000 → Nov 2002 | cancer of unknown primary site, hypoproteinemia, hypercatabolic | Dartmouth-Hitchcock Medical Center | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT03138681 | May 2017 → Apr 2019 | major depressive disorder | Zhujiang Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT02279511 | Dec 2014 → Feb 2016 | Alzheimer disease | Sara Varea | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00565188 | Mar 2002 → Oct 2006 | cancer | Maastricht University Medical Center | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT06266715 | Mar 2024 → Dec 2026 expected | depressive disorder | Nanfang Hospital, Southern Medical University | Recruiting | No outcome recorded |
| — | NCT03722849 | Mar 2019 → May 2022 | — | Stuart Mazzone | Completed | No outcome recorded |
| — | NCT02789358 | Dec 2015 → Jun 2016 | atrial fibrillation | Fundación para la Investigación del Hospital Clínico de Valencia | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07296354 Comparator | Jan 2026 → Feb 2028 expected | neuropathy, painful | Egyptian International Pharmaceutical Industries Co | Not yet recruiting | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 15 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adenosine triphosphate | “Previous studies have revealed that the decrease of bio-energetic metabolism may contribute to the occurrence of depression, while our team has found adenosine triphosphate...” PMID 30626424 ↗ Jan 201910“Intravenous administration of adenosine triphosphate combined with escitalopram in major depressive disorder: protocol for a randomised, double-blind, placebo-controlled trial.” PMID 40876882 ↗ Aug 2025 “Drugs: acetylcholine, isoproterenol, bradykinin, adenosine triphosphate, barium chloride, L-N-monomethyl Arginine Acetate, ketorolac.” NCT02833207 ↗ “adenosine triphosphate, lactate, and protons with phosphate buffer” NCT01919918 ↗ |
| Known as | Adenosine 5'-triphosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07085975 ↗ |
| Known as | Adenosine 5'-triphosphoric acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL14249 ↗ |
| Known as | ADENOSINE TRIPHOSPHATE DISODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL14249 ↗ |
| Known as | Adenosine triphosphate disodium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL14249 ↗ |
| Known as | ATP | “A previous study in patients with advanced non-small-cell lung cancer showed that adenosine 5'-triphosphate (ATP) infusions had a favourable effect on fatigue, appetite, body...” NCT00565188 ↗4“Adenosine Triphosphate (ATP) - 10 mg Cocarboxylase (Vitamin B1 derivative) - 50 mg Nicotinamide (Vitamin B3) - 20 mg Vitamin B12 (Cyanocobalamin) - 500 mcg” NCT07296354 ↗ “Participants will inhale escalating concentrations of Adenosine Triphosphate (ATP) to induce cough and the urge-to-cough” NCT03722849 ↗ “Patients receive adenosine triphosphate (ATP) IV over 8 hours on day 0.” NCT00014248 ↗ |
| Known as | Atp disodium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL14249 ↗ |
| Known as | Disodium adenosine triphosphate | ChEMBL registry synonym — accepted as the source's own label CHEMBL14249 ↗ |
| Known as | NSC-20268 | ChEMBL registry synonym — accepted as the source's own label CHEMBL14249 ↗ |
| Modality | Small molecule | — CHEMBL14249 ↗ |
| Route | Intravenous | “Patients receive adenosine triphosphate (ATP) IV over 8 hours on day 0.” NCT00014248 ↗ |